Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 9
204
Views
18
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Metabolic profiling of coumarins by the combination of UPLC-MS-based metabolomics and multiple mass defect filter

, , , , , & show all
Pages 1076-1089 | Received 30 Jan 2020, Accepted 14 Mar 2020, Published online: 26 Mar 2020

References

  • Ballesteros-Gomez A, Ballesteros J, Ortiz X, et al. (2017). Identification of novel brominated compounds in flame retarded plastics containing TBBPA by combining isotope pattern and mass defect cluster analysis. Environ Sci Technol 51:1518–26.
  • Barot KP, Jain SV, Kremer L, et al. (2015). Recent advances and therapeutic journey of coumarins: current status and perspectives. Med Chem Res 24:2771–98.
  • Barr J, Weir AJ, Brendel K, Sipes IG. (1991). Liver slices in dynamic organ culture. I. An alternative in vitro technique for the study of rat hepatic drug metabolism. Xenobiotica 21:331–9.
  • Blackledge CA, Nicholson JK, Evans JA, et al. (2002). Application of 1H- and 19F-NMR spectroscopy in the investigation of the urinary and biliary excretion of 3,5-,2,4-ditrifluoromethylbenzoic and pentafluorobenzoic acids in rat. Xenobiotica 32:605–13.
  • Bollard ME, Holmes E, Blackledge CA, et al. (1996). 1H and 19F-Nmr spectroscopic studies on the metabolism and urinary excretion of mono- and disubstituted phenols in the rat. Xenobiotica 26:255–73.
  • Castro-Perez J, Plumb R, Granger JH, et al. (2005). Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 19:843–8.
  • Chu H, Zhang A-H, Han Y, Wang X-J. (2015). Metabolomics and its potential in drug discovery and development from TCM. World J Tradition Chin Med 1:26–32.
  • Cohen AJ. (1979). Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food Cosmetics Toxicol 17:277–89.
  • Fang Z-Z, Gonzalez FJ. (2014). LC–MS-based metabolomics: an update. Arch Toxicol 88:1491–502.
  • Feng WY, Wen J, Stauber K. (2018). In vitro drug metabolism investigation of 7-ethoxycoumarin in human, monkey, dog and rat hepatocytes by high resolution LC–MS/MS. Drug Metab Lett 12:33–53.
  • Juvonen RO, Novak F, Emmanouilidou E, et al. (2019). Metabolism of scoparone in experimental animals and humans. Planta Med 85:453–64.
  • Kaighen M, Williams R. (1961). The metabolism of [3–14C]coumarin. J Med Chem 3:25–43.
  • Kleiner HE, Xia X, Sonoda J, et al. (2008). Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes inmice. Toxicol Appl Pharmacol 232:337–50.
  • Lake BG, Evans JG, Lewis DFV, Price RJ. (1994). Studies on the acute effects of coumarin and some coumarin derivatives in the rat. Food Chem Toxicol 32:357–63.
  • Lake BG, Gaudin H, Price RJ, Walters DG. (1992). Metabolism of [3–14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Food Chem Toxicol 30:105–15.
  • Lake BG, Walters DG, Gangolli SD. (1989). Comparison of the metabolism and disposition of [3–14C]coumarin in the rat and marmoset (Callithrix jacchus). Toxicol Lett 45:299–306.
  • Li F, Patterson AD, Krausz KW, et al. (2012). Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochem Pharmacol 83:1435–44.
  • Liu M, Zhao S, Wang Z, et al. (2014). Identification of metabolites of deoxyschizandrin in rats by UPLC-Q-TOF-MS/MS based on multiple mass defect filter data acquisition and multiple data processing techniques. J Chromatogr B Analyt Technol Biomed Life Sci 949–950:115–26.
  • Liu X, Lu YF, Guan XF, et al. (2015). Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism. Biochem Pharmacol 97:111–21.
  • Lv QQ, Yang XN, Yan DM, et al. (2017). Metabolic profiling of dehydrodiisoeugenol using xenobiotic metabolomics. J Pharm Biomed Anal 145:725–33.
  • Ma SG, Chowdhury SK, Alton KB. (2006). Application of mass spectrometry for metabolite identification. Curr Drug Metab 7:503–23.
  • Myers AL, Watson-Leung T, Jobst KJ, et al. (2014). Complementary nontargeted and targeted mass spectrometry techniques to determine bioaccumulation of halogenated contaminants in freshwater species. Environ Sci Technol 48:13844–54.
  • Paterson P, Fry JR, Horner SA. (1984). Influence of cytochrome P-450 type on the pattern of conjugation of 7-hydroxycoumarin generated from 7-alkoxycoumarins. Xenobiotica 14:849–59.
  • Shilling WH, Crampton RF, Longland RC. (1969). Metabolism of coumarin in man. Nature 221:664–5.
  • Srikrishna D, Godugu C, Dubey PK. (2018). A review on pharmacological properties of coumarins. Mini-Rev Med Chem 18:113–41.
  • Steensma A, Beamand JA, Walters DG, et al. (1994). Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea-pig, cynomolgus monkey and human precision liver slices. Xenobiotica 24:893–907.
  • Tian T, Jin Y, Ma Y, et al. (2015). Identification of metabolites of oridonin in rats with a single run on UPLC-Triple-TOF-MS/MS system based on multiple mass defect filter data acquisition and multiple data processing techniques. J Chromatogr B Analyt Technol Biomed Life Sci 1006:80–92.
  • Tiller PR, Romanyshyn LA. (2002). Liquid chromatography/tandem mass spectrometric quantification with metabolite screening as a strategy to enhance the early drug discovery process. Rapid Commun Mass Spectrom 16:1225–31.
  • Wang X, Lv H, Sun H, et al. (2007). Development of a rapid and validated method for investigating the metabolism of scoparone in rat using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 21:3883–90.
  • Wang Y, Zhao M, Ou Y, et al. (2016). Metabolic profile of esculin in rats by ultra high performance liquid chromatography combined with Fourier transform ion cyclotron resonance mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1020:120–8.
  • Wang YK, Xiao XR, Xu KP, Li F. (2018). Metabolic profiling of the anti-tumor drug regorafenib in mice. J Pharm Biomed Anal 159:524–35.
  • Wang YK, Yang XN, Liang WQ, et al. (2019a). A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice. Xenobiotica 49:655–70.
  • Wang YK, Yang XN, Zhu X, et al. (2019b). Role of metabolic activation in elemicin-induced cellular toxicity. J Agric Food Chem 67:8243–52.
  • Yang J, Wang X, Mamuti D, et al. (2016). Study on metabolites of aesculin and aesculetin in rat urine by HPLC–MS ∼ n. Chin J Exp Tradition Med Formulae 22:93–6.
  • Yang X-N, Lv Q-Q, Zhao Q, et al. (2017). Metabolic profiling of myrislignan by UPLC-ESI-QTOFMS-based metabolomics. RSC Adv 7:40131–40.
  • Zhang H, Zhang D, Ray K. (2003). A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J Mass Spectrom 38:1110–2.
  • Zhang J, Wen Q, Xu X, et al. (2018). In vivo metabolism of three coumarins from Chimonanthi Radix based on UHPLC–QTOF–MS/MS. Zhongguo Zhong Yao Za Zhi 43:4330–8.
  • Zhao Q, Li XM, Liu HN, et al. (2018). Metabolic map of osthole and its effect on lipids. Xenobiotica 48:285–99.
  • Zhao Q, Zhang T, Xiao XR, et al. (2019). Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity. Br J Pharmacol 176:2162–78.
  • Zhu M, Zhang H, Humphreys WG. (2011). Drug metabolite profiling and identification by high-resolution mass spectrometry. J Biol Chem 286:25419–25.
  • Zhu X, Wang YK, Yang XN, Xiao XR, et al. (2019). Metabolic activation of myristicin and its role in cellular toxicity. J Agric Food Chem 67:4328–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.